IFNB1 and myeloid sarcoma: Here, we studied the influence of IFN-β therapy on T cell immune regulation in regard to Treg control and observed that MS-related impaired suppression of T cells through Treg was significantly restored following IFN-β treatment both in vitro and in vivo.